A distinguished panel of deal-makers gathered on the third day of the 2019 BIO International Convention to discuss how these market forces will likely affect biotech and pharmaceutical deals in the future, drawing upon two recent reports: Syneos Health Dealmakers’ Intentions Study and the BIO One-on-One Partnering Forecast.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,